Search clinical trials for: Enbrel (etanercept)

Total 540 results

mAbxience Research S.L.

Recruiting

A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune Disorders (MB04-A-01-23)

Healthy Volunteers

Netherlands
Amgen

Completed

Open-label Study Using 50 Mg Liquid Etanercept Subcutaneous Injection in the Thigh to Compare an Auto-injector Device and a Manual Injection in Healthy Subjects

Healthy Men and Women
Amgen

Completed

Compare Actions in Healthy Volunteer of 50 mg Etanercept Injection Using an Auto-injector Device and Manual Injection

Healthy Men and Women
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Extension Study Evaluating Etanercept in Ankylosing Spondylitis

Ankylosing Spondylitis

Denmark, Sweden, Finland, United Kingdom
EMS

Withdrawn

Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis

Rheumatoid Arthritis

Brazil
Amgen
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

Psoriasis
Sun Yat-sen University

Completed

Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis

Ankylosing Spondylitis

China
LG Life Sciences

Completed

Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®

Healthy

Korea, Republic of
All India Institute of Medical Sciences, New Delhi

Completed

Effect Of Anti TNF Alpha Therapy And Their Adverse Effects In Ankylosing Spondylitis In A North Indian Population

Ankylosing Spondylitis

India
Amgen

Completed

Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

Arthritis, Rheumatoid; Arthritis, Psoriatic

United States, Puerto Rico
ASIS Corporation

Unknown

ASIS for Enbrel in Plaque Psoriasis (ASISinPP)

Plaque Psoriasis.

United States
Amgen

Completed

Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept

Rheumatoid Arthritis | Plaque Psoriasis

United States, Canada
Pfizer
Lincoln Medical and Mental Health Center

Terminated

Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients (CREST)

Ankylosing Spondylitis

Italy
University of Michigan Rogel Cancer Center

Completed

The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease

Acute Graft Versus Host Disease

United States
Massachusetts General Hospital
Brigham and Women's Hospital; Stanford University

Completed

Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris

Pemphigus Vulgaris

United States
Pfizer

Completed

Observational Trial With Enbrel

Rheumatoid Arthritis

Germany
Pfizer

Completed

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists

Psoriasis | Skin Diseases, Papulosquamous | Arthritis, Psoriatic

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis

Ankylosing Spondylitis
Samsung Bioepis Co., Ltd.

Completed

A Study Comparing SB4 to Enbrel® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Rheumatoid Arthritis

Poland, United Kingdom
Biogen
Samsung Bioepis Co., Ltd.

Completed

Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel (BENEFIT)

Rheumatoid Arthritis | Axial Spondyloarthritis

Germany
Pfizer

Completed

Etanercept (Enbrel) Special Investigation (Regulatory Post Marketing Commitment Plan)

Arthritis | Rheumatoid

Japan
Pfizer

Completed

Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

Spondylitis, Ankylosing
Florida Academic Dermatology Centers

Unknown

The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus (DISCLUP2008)

Discoid Lupus Erythematosus (DLE)

United States
University of Pennsylvania

Completed

Etanercept for Treatment of Hidradenitis

Hidradenitis Suppurativa
University of Alabama at Birmingham
Amgen

Completed

Can We Miss Pigmented Lesions in Psoriasis Patients?

Melanoma | Psoriasis | Non-melanoma Skin Cancer

United States
Amgen
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis

Psoriasis
National Institute of Dental and Craniofacial Research...

Completed

Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction

Inflammation | Healthy

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis

Ankylosing Spondylitis
Pfizer

Completed

Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

Rheumatoid Arthritis

Japan
Virginia Commonwealth University
University of Miami

Withdrawn

Islet After Kidney Transplant for Type 1 Diabetes

Type 1 Diabetes Mellitus

United States
Pfizer

Terminated

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department (ENBREL NIS CN)

Rheumatoid Arthritis | Ankylosing Spondylitis

China
Pfizer

Completed

Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept

Psoriasis

Italy, France, Spain, Germany, Greece, Finland, Netherlands, Sweden, Norway, Belgium, Denmark, Hungary
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety of Enbrel (Etanercept)

Arthritis, Psoriatic

Philippines
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan

Rheumatoid Arthritis
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children

Rheumatoid Arthritis
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis

Ankylosing Spondylitis
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept 25mg or 50mg Administered Subcutaneously to Healthy Chinese Male Subjects

Healthy

China
Sun Yat-sen University

Completed

Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein

Spondyloarthritis

China
Northwestern University

Enrolling by invitation

RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant

Lung Transplant; Complications

United States
University of Michigan
Amgen

Completed

The Immunological Basis for Treatment Resistance to Anti-TNF Treatments

Psoriasis

United States
Universitaire Ziekenhuizen KU Leuven
Pfizer

Completed

An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients (DERM)

Psoriasis
Hanwha Chemical

Completed

Safety and Pharmacokinetic Characteristics of HD203 Liquid in Healthy Male Volunteers

Healthy

Korea, Republic of
University of Utah

Withdrawn

Etanercept for the Treatment of Chronic Urticaria (EtanerceptCIU)

Chronic Idiopathic Urticaria

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis

Ankylosing Spondylitis

France, Germany, Netherlands, Hungary
Pfizer

Completed

Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings

Psoriasis

Germany
Pfizer

Completed

Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance] (Enbrel-JIA)

Juvenile Idiopathic Arthritis

Japan
Pfizer

Completed

A Study to Evaluate the NSAIDS Sparing Effect of Etanercept in Subjects With Axial Spondyloarthritis (SPARSE)

Axial Spondyloarthritis

France
Hanwha Chemical

Completed

Safety and Pharmacokinetic Characteristics of HD203 Liq. in Healthy Subjects

Healthy

Korea, Republic of
Erasmus Medical Center
Dutch Arthritis Association

Unknown

Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis (ABC-STOP)

Juvenile Idiopathic Arthritis

Netherlands
University of Padova
Wyeth is now a wholly owned subsidiary of Pfizer; Azienda Ospedaliera di Padova

Completed

Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis

Persistent Knee Joint Synovitis

Italy

3

Subscribe